Terms: = Lymphoma AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE
255 results:
1. Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials.
Lund JL; Cacciatore J; Tylock R; Su IH; Sharma S; Hinton SP; Smith S; Nowels MA; Chen X; Duberstein PR; Hanson LC; Mohile SG
JCO Clin Cancer Inform; 2024 Apr; 8():e2300183. PubMed ID: 38564692
[TBL] [Abstract] [Full Text] [Related]
2. Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Kater AP; Arslan Ö; Demirkan F; Herishanu Y; Ferhanoglu B; Diaz MG; Leber B; Montillo M; Panayiotidis P; Rossi D; Skarbnik A; Tempescul A; Turgut M; Mellink CH; van der Kevie-Kersemaekers AF; Lanham S; Sale B; Del Rio L; Popovic R; Chyla BJ; Busman T; Komlosi V; Wang X; Sail K; Pena GE; Vizkelety T; Forconi F
Lancet Oncol; 2024 Apr; 25(4):463-473. PubMed ID: 38467131
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic factors and clinical survival outcome in patients with primary mediastinal diffuse large B-cell lymphoma in rituximab era: A population-based study.
Hang H; Zhou H; Ma L
Medicine (Baltimore); 2024 Feb; 103(8):e37238. PubMed ID: 38394535
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of clinical profile and role of various prognostic factors in early bone marrow response in children with acute lymphoblastic leukemia treated by Modified Multicenter Protocol (MCP) 841 protocol: Experience from a tertiary care center in North India.
Garg M; Abrol P; Gupta N; Bharti S; Nadda A
Indian J Cancer; 2023 Oct; 60(4):521-527. PubMed ID: 38258870
[TBL] [Abstract] [Full Text] [Related]
5. Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study.
Kang DW; Park SK; Yu YL; Lee Y; Lee DH; Kang S
ESMO Open; 2024 Jan; 9(1):102200. PubMed ID: 38194884
[TBL] [Abstract] [Full Text] [Related]
6. A diagnostic model based on
Zhou S; Tsui P; Lin M; Chen G; Chen W; Cai X
BMC Med Imaging; 2024 Jan; 24(1):14. PubMed ID: 38191331
[TBL] [Abstract] [Full Text] [Related]
7. Histogram analysis based on unenhanced CT for identifying thymoma and lymphoma among prevascular mediastinal incidentalomas.
Liu M; Zhang Y; Liu LH
Cancer Imaging; 2024 Jan; 24(1):5. PubMed ID: 38178266
[TBL] [Abstract] [Full Text] [Related]
8. Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients.
Zhou X; Weng Y; Jiang T; Ou W; Zhang N; Dong Q; Tang X
BMC Cancer; 2023 Oct; 23(1):976. PubMed ID: 37833648
[TBL] [Abstract] [Full Text] [Related]
9. The incidence, risk factors, management and prognosis of postoperative systemic complications after ophthalmic surgery: a retrospective study at a tertiary, academic referral hospital over a decade.
Cheng SY; Wu YF; Gu XW; Zhao Q; Meng LH; Chen YX; Zhao XY
Ann Med; 2023; 55(2):2262502. PubMed ID: 37796532
[TBL] [Abstract] [Full Text] [Related]
10. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
[TBL] [Abstract] [Full Text] [Related]
11. Artificial intelligence and the blood film: Performance of the MC-80 digital morphology analyzer in samples with neoplastic and reactive cell types.
Zini G; Mancini F; Rossi E; Landucci S; d'Onofrio G
Int J Lab Hematol; 2023 Dec; 45(6):881-889. PubMed ID: 37641457
[TBL] [Abstract] [Full Text] [Related]
12. [Diagnostic and prognostic values of flow cytometry in diffuse large B-cell lymphoma with bone marrow involvement].
Hong Y; Wan WL; Li M; Wang H; Dong F; Jing HM; Ke XY; Zhu MX
Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(29):2258-2265. PubMed ID: 37544763
[No Abstract] [Full Text] [Related]
13. Sézary syndrome originates from heavily mutated hematopoietic progenitors.
Harro CM; Sprenger KB; Chaurio RA; Powers JJ; Innamarato P; Anadon CM; Zhang Y; Biswas S; Mandal G; Mine JA; Cortina C; Nagy MZ; Martin AL; Handley KF; Borjas GJ; Chen PL; Pinilla-Ibarz J; Sokol L; Yu X; Conejo-Garcia JR
Blood Adv; 2023 Sep; 7(18):5586-5602. PubMed ID: 37531660
[TBL] [Abstract] [Full Text] [Related]
14. Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial.
Jabbour E; Short NJ; Senapati J; Jain N; Huang X; Daver N; DiNardo CD; Pemmaraju N; Wierda W; Garcia-Manero G; Montalban Bravo G; Sasaki K; Kadia TM; Khoury J; Wang SA; Haddad FG; Jacob J; Garris R; Ravandi F; Kantarjian HM
Lancet Haematol; 2023 Jun; 10(6):e433-e444. PubMed ID: 37187201
[TBL] [Abstract] [Full Text] [Related]
15. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract] [Full Text] [Related]
16. CRISPR screens identify novel regulators of cFLIP dependency and ligand-independent, TRAIL-R1-mediated cell death.
Kuehnle N; Osborne SM; Liang Z; Manzano M; Gottwein E
Cell Death Differ; 2023 May; 30(5):1221-1234. PubMed ID: 36801923
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of 18F-FDG lesion dissemination features in patients with peripheral T-cell lymphoma (PTCL).
Xie Y; Teng Y; Jiang C; Ding C; Zhou Z
Jpn J Radiol; 2023 Jul; 41(7):777-786. PubMed ID: 36752954
[TBL] [Abstract] [Full Text] [Related]
18. [A comparison of C+SCAV and SEAM conditioning regimens in efficacy and safety in autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma patients].
Li JQ; Zhang Y; Geng HZ; Jia SX; Wu XJ; Zhou J; Zong XP; Yang Z; Chen XC; Ma C; Chen GH; Dai HP; Li CX; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):668-673. PubMed ID: 36709152
[No Abstract] [Full Text] [Related]
19. The Effect of Caspase 8, 9 Gene Polymorphisms on Non-Hodgkin lymphoma Susceptibility and Clinical/Pathological Features.
Barati F; Bahari G; Asadi A; Nakhaee A; Hashemi SM; Taheri M; Hashemi M
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4339-4346. PubMed ID: 36580018
[TBL] [Abstract] [Full Text] [Related]
20. Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial Intelligence.
Zhang H; Qureshi MA; Wahid M; Charifa A; Ehsan A; Ip A; De Dios I; Ma W; Sharma I; McCloskey J; Donato M; Siegel D; Gutierrez M; Pecora A; Goy A; Albitar M
Am J Pathol; 2023 Jan; 193(1):51-59. PubMed ID: 36243045
[TBL] [Abstract] [Full Text] [Related]
[Next]
